查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1630951

全球 3D 细胞培养市场：市场规模、份额和趋势分析（按技术、应用、最终用途、地区和细分市场，2025-2030 年）

3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Stem Cell Research & Tissue Engineering, Cancer Research), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

3D 细胞培养市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球3D细胞培养市场规模预计到2030年将达到32.1亿美元，2025年至2030年期间的复合年增长率为11.72%。

这个市场受到体外测试模型的技术进步、个人化医疗的日益关注以及政府对研发的支持性法律的推动。此外，慢性病发病率的不断上升以及细胞疗法在慢性病治疗中的重要性日益增加，为该行业的扩张创造了动力。

组织工程在创建 3D 培养模型方面取得了巨大进步，与传统的 2D 细胞培养相比，该模型可以更准确地模拟体内培养基。这导致 3D 细胞培养系统在毒性测试、药物研发和再生医学开发的应用增加。此外，产业参与者近期推出的产品也为市场成长提供了巨大推动力。例如，2023 年 6 月，Pixelgen Technologies 推出了首个用于对细胞表面蛋白质进行 3D 空间研究的分子像素化套件。

此外，微流体、生物列印和高内涵筛检系统等先进技术的开发正在利用这些模型的功能。这些技术可以更好地控制培养条件、细胞组织和进行高通量筛检的能力，从而促进 3D 培养系统的利用。此外，市场相关人员之间不断加强合作，利用生物列印和微流体技术开发培养模型，也有助于市场成长。例如，AIM Biotech 和 MatTek 于 2023 年 6 月建立合作，提供其创新的 identTX 和 organiX微流体3D 组织培养平台以及神经生物学、免疫肿瘤学和血管生物学等特定领域的完整药物发现研究服务。

3D 培养物正在不断地被开发用于需要体内模型来分析药物对体细胞组织和器官的影响的研究，因为它们能够忠实地再现器官的典型超微结构和形态。这一因素，加上各种体外应用的支架材料和结构的多种选择，预计将增加支架的收益。最近的研究探讨了多种支架的使用，包括石墨烯支架、奈米纤维、天然海洋胶原蛋白和冷冻铸造。此外，实验室晶片等技术在多种检测类型的应用，包括增殖、刺激、活力、运输、高内涵筛检、膜片钳和代谢活动，预计将导致对先进高效解决方案的需求不断增加。

然而，3D 细胞模型产品缺乏一致性是预期会阻碍市场成长的主要缺点之一。此外，细胞培养变异性、标准化挑战、规模和製造问题以及品管问题等各种因素都可能阻碍市场成长。

3D 细胞培养市场：分析概述

  • 基于鹰架的部分在 2024 年占据了最大的收益占有率，为 48.85%。此部分分为水凝胶、聚合物支架、微图案表面工程微孔盘和基于奈米纤维的支架。
  • 2024 年，干细胞研究和组织工程领域占据市场主导地位，份额为 34.23%。市场分为癌症研究、干细胞研究和组织工程、药物开发和毒性测试等。
  • 就最终用途领域而言，生物製药和製药公司领域在 2024 年占据市场主导地位，份额为 46.93%。市场分为生物技术和製药公司、学术研究机构、医院等。
  • 北美 3D 细胞培养市场占据全球市场主导地位，到 2024 年将占 39.09% 的份额。市场受到先进（2018-2030）基础设施、新兴经济体、主要企业的存在以及他们采取的各种策略倡议的共同驱动。

目录

第一章 分析方法及范围

第 2 章执行摘要

第三章 市场驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 产业分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章 业务技术分析

  • 3D 细胞培养市场：依技术进行差异分析
  • 鹰架底座
    • 基于鹰架的市场规模、估计值和预测（2018-2030 年）
    • 水凝胶
    • 聚合物支架
    • 微图案表面微孔盘
    • 奈米纤维支架
  • 无支架
    • 无鹰架市场规模、估计值及预测值（2018-2030）
    • 悬滴微孔盘
    • ULA 涂层球状微孔盘
    • 磁浮
  • 生物反应器
    • 生物反应器市场规模、估计值和预测（2018-2030）
  • 微流体
    • 微流体市场规模、估计值与预测（2018-2030 年）
  • 生物列印
    • 生物列印市场规模、估计值和预测（2018-2030 年）

第 5 章 按应用程式进行的业务分析

  • 3D 细胞培养市场：依应用进行的变化分析
  • 癌症研究
    • 癌症研究市场规模、估计值和预测（2018-2030 年）
  • 干细胞研究与组织工程
    • 干细胞研究和组织工程市场规模、估计值和预测（2018-2030 年）
  • 药物开发和毒性测试
    • 药物开发和毒性测试市场规模、估计值和预测（2018-2030 年）
  • 其他的
    • 其他城市市场规模估计值及预测（2018-2030 年）

第六章 最终用途业务分析

  • 3D 细胞培养市场：依最终用途进行的变化分析
  • 生物技术和製药公司
    • 生物技术和製药公司市场规模、估计值和预测（2018-2030 年）
  • 学术研究所
    • 学术研究机构市场规模、估计值与预测（2018-2030 年）
  • 医院
    • 医院市场规模、估计值和预测（2018-2030 年）
  • 其他的
    • 其他市场规模、估计值和预测（2018-2030 年）

第七章 区域经营分析

  • 3D 细胞培养市场：区域份额（2024 年和 2030 年）
  • 北美洲
    • 北美 3D 细胞培养市场（2018-2030 年）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲 3D 细胞培养市场（2018-2030 年）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区 3D 细胞培养市场（2018-2030 年）
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲 3D 细胞培养市场（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲 3D 细胞培养市场（2018-2030 年）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
  • 战略地图
  • 企业市场分析（2024）
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • PromoCell GmbH
    • Lonza
    • Corning Incorporated
    • Avantor, Inc.
    • Tecan Trading AG
    • REPROCELL Inc.
    • CN Bio Innovations Ltd.
    • Lena Biosciences
Product Code: GVR-1-68038-091-0

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is expected to reach USD 3.21 billion by 2030, registering a CAGR of 11.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

  • The scaffold-based segment held the largest revenue share of 48.85% in 2024. The segment is divided into hydrogels, polymeric scaffolds, micropatterned surfaced microplates, and nanofiber-based scaffolds.
  • The stem cell research & tissue engineering segment dominated the market with a share of 34.23% in 2024. The market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others.
  • In the end-use segment, the biopharmaceutical & pharmaceutical companies segment dominated the market with a share of 46.93% in 2024. The market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others.
  • North America 3D cell culture market dominated the global market and accounted for 39.09% share in 2024. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
      • 3.2.1.2. Technological advancements in scaffold free technology
      • 3.2.1.3. Rise in investments and R&D funding for cell-based research
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with implementation
      • 3.2.2.2. Lack of compatibility and consistency
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. 3D Cell Culture Market: Technology Movement Analysis
  • 4.2. Scaffold Based
    • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Hydrogels
      • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Polymeric Scaffolds
      • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Micropatterned Surface Microplates
      • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Nanofiber Based Scaffolds
      • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Scaffold Free
    • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Hanging Drop Microplates
      • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Spheroid Microplates with ULA coating
      • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Magnetic Levitation
      • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bioreactors
    • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Microfluidics
    • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bioprinting
    • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. 3D Cell Culture Market: Application Movement Analysis
  • 5.2. Cancer Research
    • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Stem Cell Research & Tissue Engineering
    • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Development & Toxicity Testing
    • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. 3D Cell Culture Market: End Use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. 3D Cell Culture Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Target Disease Prevalence
      • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Target Disease Prevalence
      • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Target Disease Prevalence
      • 7.2.4.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
      • 7.2.4.5.
  • 7.3. Europe
    • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Target Disease Prevalence
      • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Target Disease Prevalence
      • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Target Disease Prevalence
      • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Target Disease Prevalence
      • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Target Disease Prevalence
      • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Target Disease Prevalence
      • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Target Disease Prevalence
      • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Target Disease Prevalence
      • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Target Disease Prevalence
      • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Target Disease Prevalence
      • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Target Disease Prevalence
      • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Target Disease Prevalence
      • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Target Disease Prevalence
      • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Target Disease Prevalence
      • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Target Disease Prevalence
      • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Target Disease Prevalence
      • 7.5.3.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Target Disease Prevalence
      • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Target Disease Prevalence
      • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Target Disease Prevalence
      • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Target Disease Prevalence
      • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PromoCell GmbH
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Corning Incorporated
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Avantor, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Tecan Trading AG
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. REPROCELL Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. CN Bio Innovations Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Lena Biosciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 24 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 26 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 27 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 France 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 31 Italy 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 Spain 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 49 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 China 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 54 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 55 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 India 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 57 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 58 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 69 Latin America 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 72 Brazil 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE 3D cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait 3D cell culture market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 3D cell culture market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 3D cell culture market driver impact
  • Fig. 11 3D cell culture market restraint impact
  • Fig. 12 3D cell culture market: technology outlook and key takeaways
  • Fig. 13 3D cell culture market: technology movement analysis
  • Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 3D cell culture market: application outlook and key takeaways
  • Fig. 27 3D cell culture market: application movement analysis
  • Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 3D cell culture market: end use outlook and key takeaways
  • Fig. 33 3D cell culture market: end use movement analysis
  • Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)